GSK (GSK) said Thursday it will stop setting diversity targets, citing US legal concerns amid President Donald Trump's executive orders rolling back federal diversity, equity, and inclusion programs.
The drugmaker said it has largely met past goals for improving ethnic and gender diversity in leadership.
GSK reaffirmed it is committed to an inclusive workplace but added that it will no longer pursue "aspirational targets" for leadership and supplier diversity.
"We expect to make changes in several areas related to inclusion, including no longer setting leadership aspirations," the company said in its annual report.
GSK shares were edging 0.2% lower in recent trading.
Price: 37.31, Change: -0.09, Percent Change: -0.24
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。